EUVIMEDEUVIMED entdecken
Crossref

Investigation of CTLA-4 gene polymorphisms in a sample of Iraqi children with newly diagnosed type 1 diabetes mellitus

Ealaf Abbas Khudair, Arwa Mujahid Al-Shuwaikh, Dawood Salman Abdoun

Journal of Nephropharmacology · 26.07.2025 · 15 (1) · e12702

DOI: 10.34172/npj.2025.12702 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nephropharmacology, online erschienen am 26.07.2025. Verfasst von Ealaf Abbas Khudair und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Type 1 diabetes mellitus (T1DM) is a complicated autoimmune disorder that is marked by the destruction of pancreatic islands by T cells. It is widely believed that genetic factors play a crucial role in the development of T1DM and other autoimmune diseases. At present, the contribution of the gene cytotoxic T-lymphocyte antigen-4 (CTLA4) to type 1 diabetes has not been fully determined.

Objectives

The primary objective of this research was to examine the relationship between the CTLA-4 [-1722T/C (rs733618) and -318 C/T (rs5742909)] polymorphisms and the onset of T1DM in Iraqi children. Patients and Methods: In this case-control study, a total of one hundred children were examined. Specifically, fifty children diagnosed with T1DM and fifty age and sex-matched non-diabetic children were recruited as controls. The polymerase chain reaction (PCR) technique was employed using the allele-specific PCR method to analyze the CTLA-4 [-1722T/C (rs733618)] and [-318 C/T (rs5742909)] polymorphisms. The levels of glutamic acid decarboxylase antibody (anti-GAD Ab), anti-islet antigen-2 antibody (anti-IA-2 Ab), and insulin were determined using the enzyme-linked immunosorbent assay (ELISA) method.

Results

Children with T1DM showed significantly higher levels of anti-IA2 and anti-GAD than healthy controls, while patients had significantly lower levels of insulin than healthy controls. However, there was no statistically significant relationship between CTLA-4 polymorphisms -1722T/C (rs733618) and -318 (rs5742909) and anti-GAD Ab, anti-IA-2 Ab, with insulin levels in T1DM patients and controls.

Conclusion

The findings of the present investigation indicate that neither CTLA-4 polymorphism -1722T/C (rs733618) nor CTLA-4 polymorphism -318 (rs5742909) are associated with genetic predisposition to T1DM.

Zitieren

APA

Khudair, E. A., Al-Shuwaikh, A. M., & Abdoun, D. S. (2025). Investigation of CTLA-4 gene polymorphisms in a sample of Iraqi children with newly diagnosed type 1 diabetes mellitus. Journal of Nephropharmacology, 15(1), e12702. https://doi.org/10.34172/npj.2025.12702

Vancouver

Khudair EA, Al-Shuwaikh AM, Abdoun DS. Investigation of CTLA-4 gene polymorphisms in a sample of Iraqi children with newly diagnosed type 1 diabetes mellitus. Journal of Nephropharmacology. 2025;15(1):e12702. doi:10.34172/npj.2025.12702

BibTeX
@article{Khudair2025,
  author = {Khudair, Ealaf Abbas and Al-Shuwaikh, Arwa Mujahid and Abdoun, Dawood Salman},
  title = {Investigation of CTLA-4 gene polymorphisms in a sample of Iraqi children with newly diagnosed type 1 diabetes mellitus},
  journal = {Journal of Nephropharmacology},
  year = {2025},
  volume = {15},
  number = {1},
  pages = {e12702},
  doi = {10.34172/npj.2025.12702}
}
Kostenlos starten →